Literature DB >> 2224744

Cognitive and affective disorders in elderly diabetics.

P A Tun1, D M Nathan, L C Perlmuter.   

Abstract

In non-insulin-dependent diabetes mellitus, performance of complex cognitive tasks requiring the storage and retrieval of new information is poorer than in age-matched controls. By contrast, performance of less demanding tasks such as immediate memory and simple reaction time is essentially equivalent for NIDDM patients and controls. This pattern parallels the cognitive change observed with normal aging, in which age differences are minimal on less demanding immediate memory tasks but older adults perform more poorly than young adults on secondary or long-term memory tasks. Age-related changes in cognitive performance have been attributed to a reduction in processing resources or working memory capacity. Although the explanation for NIDDM-related deficits remains to be identified, reduced glucose control and elevated levels of triglycerides appear to play some role in cognitive impairment. Non-insulin-dependent diabetes is associated not only with elevated levels of depression, but with an increased frequency of self-reported memory problems. Moreover, elevated levels of depression are associated with various indicators of neuropathy and with significant reductions in self-regulated control of glucose at the time of medical office visits. Diabetic patients may perceive less control over their lives as a result of the many restrictions associated with the disease. When provided with the opportunity to exercise control, however, performance on many cognitive tasks can be improved in NIDDM as well as in age-matched controls. This suggests that by providing NIDDM patients with opportunities to exercise increased control over their lives it may be possible to enhance motivation and to increase the likelihood of the patient's adopting more effective self-regulatory behaviors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2224744

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  10 in total

Review 1.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 2.  Type II diabetes and quality of life: a review of the literature.

Authors:  J O Hörnquist; A Wikby; U Stenström; P O Andersson; I Akerlind
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

3.  Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging.

Authors:  C J Maxwell; D B Hogan; E M Ebly
Journal:  CMAJ       Date:  1999-09-07       Impact factor: 8.262

Review 4.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Depression in Asthma: Prevalence and Clinical Implications.

Authors:  Tanya A. Zielinski; E Sherwood Brown; Vicki A. Nejtek; David A. Khan; Jacob J. Moore; A John Rush
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

6.  Preventive effect of Teucrium polium on learning and memory deficits in diabetic rats.

Authors:  Parisa Hasanein; Siamak Shahidi
Journal:  Med Sci Monit       Date:  2012-01

7.  Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials.

Authors:  Zi Ye; Lili Chen; Zhen Yang; Qin Li; Ying Huang; Min He; Shuo Zhang; Zhaoyun Zhang; Xuanchun Wang; Weiwei Zhao; Ji Hu; Chao Liu; Shen Qu; Renming Hu
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

8.  Beneficial Effects of Teucrium polium and Metformin on Diabetes-Induced Memory Impairments and Brain Tissue Oxidative Damage in Rats.

Authors:  S Mojtaba Mousavi; Saeed Niazmand; Mahmoud Hosseini; Zarha Hassanzadeh; Hamid Reza Sadeghnia; Farzaneh Vafaee; Zakieh Keshavarzi
Journal:  Int J Alzheimers Dis       Date:  2015-02-24

9.  Insulin and insulin-like growth factor prevent brain atrophy and cognitive impairment in diabetic rats.

Authors:  Predrag Serbedžija; Douglas N Ishii
Journal:  Indian J Endocrinol Metab       Date:  2012-12

10.  Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats.

Authors:  Xiang-Sheng Cai; Zhao-Guang Tan; Jing-Jing Li; Wei-Hong Gao; Shu-Ji Li; Jin-Long Li; Yong-Ming Tang; Hong-Wei Li; Hong-Xiang Hui
Journal:  Med Sci Monit       Date:  2017-09-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.